Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P L Stetson

Showing results (11-20 of 43) with videos related to

Pageof 5
Sort By:
Research Communications in Chemical Pathology and Pharmacology|February 1, 1981
Specific and sensitive assays for digoxin in plasma, urine and heart tissueJ A Morais, R A Zlotecki, E Sakmar, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 1992
Modulation of iododeoxyuridine-mediated radiosensitization by 5-fluorouracil in human colon cancer cellsT S Lawrence, M A Davis, J Maybaum, et al.
Analytical Biochemistry|February 15, 1987
Analysis of bromodeoxyuridine incorporation into DNA: comparison of gas chromatographic/mass spectrometric, CsCl gradient sedimentation, and specific radioactivity methodsJ Maybaum, M G Kott, N J Johnson, et al.
Cancer Research|June 1, 1994
Kinetics of bromodeoxyuridine elimination from human colon cancer cells in vitro and in vivoT S Lawrence, M A Davis, P L Stetson, et al.
Journal of Neurosurgery|June 1, 1984
BCNU solubility and toxicity in the treatment of malignant astrocytomasP B Layton, H S Greenberg, P L Stetson, et al.
International Journal of Radiation Oncology, Biology, Physics|February 1, 1996
Effect of irradiation on bromodeoxyuridine incorporation in human colon cancer xenograftsT S Lawrence, E Y Chang, M A Davis, et al.
The Journal of Biological Chemistry|August 10, 2000
Rabbit serum paraoxonase 3 (PON3) is a high density lipoprotein-associated lactonase and protects low density lipoprotein against oxidationD I Draganov, P L Stetson, C E Watson, et al.
Cancer Research|July 4, 1998
Preferential cytotoxicity of cells transduced with cytosine deaminase compared to bystander cells after treatment with 5-flucytosineT S Lawrence, A Rehemtulla, E Y Ng, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
Response of human HT-29 colorectal tumor cells to extended exposure to bromodeoxyuridineJ Maybaum, M S Hafner, E C Burton, et al.
Cancer Research|February 1, 1991
Variability of 5-bromo-2'-deoxyuridine incorporation into DNA of human glioma cell lines and modulation with fluoropyrimidinesW R Mancini, P L Stetson, T S Lawrence, et al.
Pageof 5

Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
Research Communications in Chemical Pathology and Pharmacology|February 1, 1981
Specific and sensitive assays for digoxin in plasma, urine and heart tissueJ A Morais, R A Zlotecki, E Sakmar, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 1992
Modulation of iododeoxyuridine-mediated radiosensitization by 5-fluorouracil in human colon cancer cellsT S Lawrence, M A Davis, J Maybaum, et al.
Analytical Biochemistry|February 15, 1987
Analysis of bromodeoxyuridine incorporation into DNA: comparison of gas chromatographic/mass spectrometric, CsCl gradient sedimentation, and specific radioactivity methodsJ Maybaum, M G Kott, N J Johnson, et al.
Cancer Research|June 1, 1994
Kinetics of bromodeoxyuridine elimination from human colon cancer cells in vitro and in vivoT S Lawrence, M A Davis, P L Stetson, et al.
Journal of Neurosurgery|June 1, 1984
BCNU solubility and toxicity in the treatment of malignant astrocytomasP B Layton, H S Greenberg, P L Stetson, et al.
International Journal of Radiation Oncology, Biology, Physics|February 1, 1996
Effect of irradiation on bromodeoxyuridine incorporation in human colon cancer xenograftsT S Lawrence, E Y Chang, M A Davis, et al.
The Journal of Biological Chemistry|August 10, 2000
Rabbit serum paraoxonase 3 (PON3) is a high density lipoprotein-associated lactonase and protects low density lipoprotein against oxidationD I Draganov, P L Stetson, C E Watson, et al.
Cancer Research|July 4, 1998
Preferential cytotoxicity of cells transduced with cytosine deaminase compared to bystander cells after treatment with 5-flucytosineT S Lawrence, A Rehemtulla, E Y Ng, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
Response of human HT-29 colorectal tumor cells to extended exposure to bromodeoxyuridineJ Maybaum, M S Hafner, E C Burton, et al.
Cancer Research|February 1, 1991
Variability of 5-bromo-2'-deoxyuridine incorporation into DNA of human glioma cell lines and modulation with fluoropyrimidinesW R Mancini, P L Stetson, T S Lawrence, et al.
Pageof 5